Hein T W, Belardinelli L, Kuo L
Department of Medical Physiology, Cardiovascular Research Institute, Texas A&M University System Health Science Center, College Station, Texas 77843-1114, USA.
J Pharmacol Exp Ther. 1999 Nov;291(2):655-64.
Adenosine is a potent vasodilator that plays an important role in the regulation of coronary microvascular diameter. Although multiple adenosine receptor subtypes have been recently cloned, the specific adenosine receptor subtypes and the underlying mechanisms responsible for the vasodilation to adenosine in the coronary microcirculation remain unknown. Therefore, in the present study we determined the receptor subtypes for coronary arteriolar dilation to adenosine and investigated the role of nitric oxide (NO) and ATP-sensitive potassium (K(ATP)) channels in this vasodilatory response. Pig coronary arterioles (50-100 microm in situ) were isolated, cannulated, and pressurized without flow for in vitro study. Arterioles developed basal tone and dilated in a concentration-dependent manner to adenosine and to adenosine receptor agonists (2S)-N(6)-[2-endo-norbornyl]adenosine (A(1)), 2-[p-(2-carboxyethyl)]phenylethyl-amino-5'-N-ethylcarboxamidoadenosin e (CGS21680; A(2A)), N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (A(3)), and N-ethylcarboxamidoadenosine (nonselective adenosine receptor activation). The selective A(2A) receptor antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]-triazolo[2,3-a][1,3,5]triazin-5-y l amino]ethyl)phenol attenuated vasodilation to adenosine and to all adenosine receptor agonists tested, suggesting that the vasodilatory responses were primarily mediated by A(2A) receptors. Adenosine- and CGS21680-induced dilations were attenuated in a similar manner by endothelial removal and by the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester. In denuded vessels, both adenosine- and CGS21680-induced dilations were nearly abolished by the K(ATP) channel inhibitor glibenclamide. The selective A(2A) agonist CGS21680 mechanistically mimics the vasodilation in response to adenosine. Collectively, our results suggest that the dilation of coronary arterioles to adenosine is mediated predominantly by A(2A) receptors. Activation of this receptor subtype elicits vasodilation by endothelial release of NO and by the smooth muscle opening of K(ATP) channels.
腺苷是一种强效血管舒张剂,在冠状动脉微血管直径的调节中发挥重要作用。尽管最近已克隆出多种腺苷受体亚型,但在冠状动脉微循环中,介导腺苷血管舒张作用的具体受体亚型及其潜在机制仍不清楚。因此,在本研究中,我们确定了冠状动脉小动脉对腺苷舒张反应的受体亚型,并研究了一氧化氮(NO)和ATP敏感性钾(K(ATP))通道在这种血管舒张反应中的作用。分离猪冠状动脉小动脉(原位直径50 - 100微米),插管并在无血流状态下加压用于体外研究。小动脉产生基础张力,并以浓度依赖的方式对腺苷以及腺苷受体激动剂(2S)-N(6)-[2-endo-降冰片基]腺苷(A(1))、2-[对-(2-羧乙基)]苯乙胺基-5'-N-乙基羧酰胺腺苷(CGS21680;A(2A))、N(6)-(3-碘苄基)腺苷-5'-N-甲基脲苷(A(3))和N-乙基羧酰胺腺苷(非选择性腺苷受体激活)舒张。选择性A(2A)受体拮抗剂4-(2-[7-氨基-2-(2-呋喃基)[1,2,4]-三唑并[2,3-a][1,3,5]三嗪-5-基氨基]乙基)苯酚减弱了对腺苷以及所有测试的腺苷受体激动剂的血管舒张作用,提示血管舒张反应主要由A(2A)受体介导。腺苷和CGS21680诱导的舒张作用在内皮去除和一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯作用下以相似的方式减弱。在去内皮血管中,腺苷和CGS21680诱导的舒张作用几乎都被K(ATP)通道抑制剂格列本脲消除。选择性A(2A)激动剂CGS21680在机制上模拟了对腺苷的血管舒张作用。总的来说,我们的结果提示冠状动脉小动脉对腺苷的舒张作用主要由A(2A)受体介导。该受体亚型的激活通过内皮释放NO和平滑肌K(ATP)通道开放引发血管舒张。